O-0021 Randomised Phase III Study of Bevacizumab + Chemotherapy Beyond Progression in Bevacizumab-Treated Patients with Metastatic Colorectal Cancer: TML Study Kras Subgroup Findings

Annals of Oncology - Tập 23 - Trang iv15 - 2012
Eric Van Cutsem1, Jose Maria Vieitez2, Olivier Bouché3, Pia Österlund4, Jaafar Bennouna5, Thierry André6, Javier Sastre7, Vicente Alonso-Orduna8, Stefan Kubicka9, Richard Greil10, Roger von Moos11, Irmarie Reyes-Rivera12, Stefan Scherer12, Belguendouz Bendahmane13, Dirk Arnold14
1University Hospital Gasthuisberg, Leuven, Flemish Brabant
2Central University Hospital of Asturias (HUCA), Oviedo
3Centre Hospitalier Universitaire Robert Debré, Reims, Cedex
4Helsinki University Central Hospital, Helsinki
5Institut de Cancérologie de l'Ouest, Nantes, St Herblain
6Hopital Saint-Antoine, Paris
7Servicio de Oncología Médica HC, Madrid
8Hospital Universitario Miguel Servet. Zaragoza
9Cancer Center Reutlingen, Reutlingen
10III Medizinische Universitätsklinik Salzburg, Salzburg
11Kantonsspital Graubuenden, Chur
12Genentech, Inc., South San Francisco, California
13F. Hoffmann-La Roche, Basel
14Hubertus Wald Tumor Center, University Cancer Center Hamburg (UCCH), Hamburg

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 23

iv15

Thông tin tác giả